NorthStar and Bayer reach Ac-225 supply deal

2018 12 11 00 02 7009 Atom Nuclear Lab 400

NorthStar Medical Isotopes will supply Bayer with the medical radioisotope actinium-225 (Ac-225).

Under the terms of the deal, NorthStar will provide Bayer with non-carrier-added Ac-225 to be used by Bayer for several of its radiopharmaceutical programs. Ac-225 is a high-energy alpha-emitting radioisotope used in clinical trials to deliver therapeutic doses of radiation to destroy cancer cells in patients.

The radioisotope will be produced at a new dedicated Ac-225 production facility at NorthStar's Beloit, WI, campus, with the first shipments planned in 2024.

Page 1 of 589
Next Page